Answer
Systemic NSAIDs can reduce indapamide’s blood-pressure-lowering effect and increase the risk of acute renal failure in dehydrated patients through decreased glomerular filtration; patients should be hydrated and kidney function monitored at the start of treatment.
Sources for this answer
- Natrilix SRServier Laboratories Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 14Document updated
Sources checked